ELP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.490410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.288570E-01
Normal-vs-Stage2
1.307210E-01
Normal-vs-Stage3
7.440200E-02
Normal-vs-Stage4
3.809400E-01
Stage1-vs-Stage2
8.398400E-01
Stage1-vs-Stage3
4.505800E-01
Stage1-vs-Stage4
4.084000E-01
Stage2-vs-Stage3
3.543800E-01
Stage2-vs-Stage4
5.153600E-01
Stage3-vs-Stage4
1.597250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.535400E-01
Normal-vs-AfricanAmerican
3.134600E-01
Normal-vs-Asian
5.086200E-02
Caucasian-vs-AfricanAmerican
5.734200E-01
Caucasian-vs-Asian
1.431390E-01
AfricanAmerican-vs-Asian
1.391360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.020760E-01
Normal-vs-Female
2.356200E-01
Male-vs-Female
7.951800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.003600E-01
Normal-vs-Age(41-60Yrs)
3.369400E-01
Normal-vs-Age(61-80Yrs)
9.492200E-02
Normal-vs-Age(81-100Yrs)
1.971020E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.237800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.052400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.674200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.716200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.560400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.106800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.963510E-02
Normal-vs-Daily Drinker
1.501870E-02
Normal-vs-Weekly Drinker
2.240400E-01
Normal-vs-Occasional Drinker
1.755410E-01
Normal-vs-Social Drinker
9.196200E-01
Non Drinker-vs-Daily Drinker
8.207000E-01
Non Drinker-vs-Weekly Drinker
4.789500E-02
Non Drinker-vs-Occasional Drinker
3.820300E-02
Non Drinker-vs-Social Drinker
7.497400E-03
Daily Drinker-vs-Weekly Drinker
3.668300E-02
Daily Drinker-vs-Occasional Drinker
2.878300E-02
Daily Drinker-vs-Social Drinker
5.957500E-03
Weekly Drinker-vs-Occasional Drinker
9.245600E-01
Weekly Drinker-vs-Social Drinker
1.713000E-01
Occasional Drinker-vs-Social Drinker
1.328580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.087400E-01
Normal-vs-Grade 2
7.645200E-01
Normal-vs-Grade 3
7.675600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.352800E-01
Grade 1-vs-Grade 3
6.411800E-01
Grade 1-vs-Grade 4
4.087400E-01
Grade 2-vs-Grade 3
9.526600E-01
Grade 2-vs-Grade 4
7.645200E-01
Grade 3-vs-Grade 4
7.675600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.706100E-02
Normal-vs-NonDiabetic
1.665840E-01
Diabetic-vs-NonDiabetic
1.712380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.452000E-02
Normal-vs-NoPancreatitis
1.421390E-01
Pancreatitis-vs-NoPancreatitis
2.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.117000E-01
Normal-vs-N1
1.407810E-01
N0-vs-N1
6.562400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.464300E-02
Normal-vs-TP53-NonMutant
4.423200E-01
TP53-Mutant-vs-TP53-NonMutant
2.196000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
